Raiffeisen Bank International AG Acquires 40,000 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Raiffeisen Bank International AG raised its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 33.3% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 160,000 shares of the company’s stock after buying an additional 40,000 shares during the quarter. Raiffeisen Bank International AG owned about 0.17% of Acadia Healthcare worth $4,819,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in ACHC. Treasurer of the State of North Carolina raised its position in shares of Acadia Healthcare by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company’s stock worth $1,586,000 after acquiring an additional 250 shares in the last quarter. Coldstream Capital Management Inc. raised its position in shares of Acadia Healthcare by 4.9% in the 4th quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company’s stock worth $257,000 after acquiring an additional 303 shares in the last quarter. Covestor Ltd raised its position in shares of Acadia Healthcare by 27.2% in the 4th quarter. Covestor Ltd now owns 1,450 shares of the company’s stock worth $58,000 after acquiring an additional 310 shares in the last quarter. PNC Financial Services Group Inc. raised its position in shares of Acadia Healthcare by 10.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company’s stock worth $202,000 after acquiring an additional 622 shares in the last quarter. Finally, LPL Financial LLC raised its position in shares of Acadia Healthcare by 1.2% in the 1st quarter. LPL Financial LLC now owns 56,527 shares of the company’s stock worth $1,651,000 after acquiring an additional 697 shares in the last quarter.

Acadia Healthcare Price Performance

Shares of ACHC opened at $21.09 on Monday. The company has a market capitalization of $1.94 billion, a P/E ratio of 10.39, a price-to-earnings-growth ratio of 4.02 and a beta of 0.88. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.72. The firm has a 50 day moving average of $22.49 and a 200 day moving average of $28.50. Acadia Healthcare Company, Inc. has a twelve month low of $20.35 and a twelve month high of $82.40.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.05. The business had revenue of $770.51 million during the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a net margin of 5.94% and a return on equity of 8.72%. The company’s quarterly revenue was up .3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.84 EPS. As a group, equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on ACHC. KeyCorp decreased their target price on Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating for the company in a research report on Wednesday, May 14th. Mizuho dropped their price target on Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 14th. Wall Street Zen raised Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Sunday. Guggenheim assumed coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They issued a “buy” rating and a $36.00 price target on the stock. Finally, Barclays dropped their price target on Acadia Healthcare from $35.00 to $28.00 and set an “equal weight” rating on the stock in a research report on Wednesday, May 14th. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $47.94.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.